News Search

Dr. Al-Dalahmah received the prize for his outstanding work to discover ways of increasing the brain’s ability to protect itself from damage caused by Huntington’s disease.

A treatment that prevents an often-fatal disease in fetuses and newborns only reaches half of the pregnant women around the world who need it, Columbia researchers have found.

Minah KIm, PhD, is one of the four Columbia cancer researchers selected to share seed funding raised from Velocity, Columbia’s Ride to End Cancer.

Kedrion Biopharma, a leading international biopharmaceutical company, partners with Columbia University Irving Medical Center to accelerate the development of an anti-COVID IgG therapy.